Owens & Minor (OMI) Scheduled to Post Quarterly Earnings on Friday

Owens & Minor (NYSE:OMI) is scheduled to post its quarterly earnings results before the market opens on Friday, May 3rd. Analysts expect Owens & Minor to post earnings of $0.17 per share for the quarter. Owens & Minor has set its FY 2024 guidance at 1.400-1.700 EPS and its FY24 guidance at $1.40-$1.70 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Tuesday, February 20th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.66 by $0.03. Owens & Minor had a positive return on equity of 11.62% and a negative net margin of 0.40%. The company had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.67 billion. During the same period in the previous year, the company posted $0.28 earnings per share. Owens & Minor’s revenue for the quarter was up 4.1% on a year-over-year basis. On average, analysts expect Owens & Minor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Owens & Minor Trading Down 3.1 %

Shares of NYSE:OMI opened at $23.98 on Thursday. Owens & Minor has a 12-month low of $13.34 and a 12-month high of $28.35. The company has a market capitalization of $1.84 billion, a PE ratio of -44.46, a PEG ratio of 0.80 and a beta of 0.43. The business has a 50 day moving average of $25.39 and a two-hundred day moving average of $21.33. The company has a current ratio of 1.11, a quick ratio of 0.52 and a debt-to-equity ratio of 2.05.

Insider Buying and Selling at Owens & Minor

In other news, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total value of $250,000.00. Following the transaction, the senior vice president now owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, SVP Michael Wayne Lowry sold 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total transaction of $250,000.00. Following the transaction, the senior vice president now owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Jonathan A. Leon sold 5,000 shares of the stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $24.84, for a total value of $124,200.00. Following the transaction, the senior vice president now directly owns 84,673 shares in the company, valued at approximately $2,103,277.32. The disclosure for this sale can be found here. 2.62% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Barclays boosted their price target on Owens & Minor from $21.00 to $23.00 and gave the company an “equal weight” rating in a report on Wednesday, February 21st. TheStreet upgraded Owens & Minor from a “d+” rating to a “c-” rating in a research report on Monday, March 4th. Robert W. Baird boosted their price objective on Owens & Minor from $24.00 to $28.00 and gave the company a “neutral” rating in a research report on Wednesday, April 10th. Citigroup boosted their price target on Owens & Minor from $24.00 to $28.00 and gave the stock a “neutral” rating in a research report on Tuesday. Finally, Leerink Partnrs reiterated a “market perform” rating on shares of Owens & Minor in a research report on Monday, February 26th. One analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Owens & Minor currently has an average rating of “Hold” and an average price target of $23.86.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.